Lynda Charters

Articles by Lynda Charters

Raising awareness: Dissemination of information to help patients get ahead of glaucoma

ByLynda Charters

January 23rd 2020

Mobile glaucoma apps may play limited role in awareness, education

ByLynda Charters

January 23rd 2020

'Nepafenac may reduce macular volume

ByLynda Charters

July 1st 2011

Use of nepafenac may decrease macular volume more rapidly after surgery to repair epiretinal membranes.

Olopatadine: Once-daily dosing benefit

ByLynda Charters

February 1st 2011

Olopatadine hydrochloride ophthalmic solution 0.2%, a combination mast cell stabilizer and antihistamine, effectively relieves the itching associated with allergic conjunctivitis with once-daily dosing.

Lynda Charters

Articles by Lynda Charters

Raising awareness: Dissemination of information to help patients get ahead of glaucoma

Mobile glaucoma apps may play limited role in awareness, education

'Nepafenac may reduce macular volume

Olopatadine: Once-daily dosing benefit

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

“Family business?” Navigating the business of treating family

Ortho-k: More than meets the eye to control myopia progression

ONL Therapeutics reports positive phase 1b data for xelafaslatide in GA

Improved grading scales for oncology drugs causing ocular adverse events

What advancements optometrists are hoping for in 2026: Part 1